A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf

NCT01265537 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Acute Graft Rejection
Diabetes

Interventions

DRUG: Tacrolimus
DRUG: Tacrolimus

Sponsor

University of British Columbia

Collaborators

[object Object]